VBI Vaccines Inc/BC — key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023)

$8.7M

Net Income/Loss (FY2023)

-$92.8M

Total Assets (FY2023)

$87.0M

Total Equity (FY2023)

$7.5M

Cash Flows from Operating Activities (FY2023)

-$60.9M

Source: VBI Vaccines Inc/BC 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.